About Winston Psychiatric Associates
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment
External Opioid Medications Source
Other contracted prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
Other contracted prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Medication for mental disorders; Nicotine replacement
Treatment Approaches
Motivational interviewing; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
Payment/Insurance/Funding Accepted
Medicare; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Young adults; Adult women; Adult men; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Metabolic syndrome monitoring
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy
Smoking not permitted
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping not permitted
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment
External Opioid Medications Source
Other contracted prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
Other contracted prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Medication for mental disorders; Nicotine replacement
Treatment Approaches
Motivational interviewing; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
Payment/Insurance/Funding Accepted
Medicare; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Young adults; Adult women; Adult men; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Metabolic syndrome monitoring
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy
Smoking not permitted
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping not permitted
